TB Alternative Assets’s Chemours CC Stock Holding History

TB Alternative Assets’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-155,900	Closed	-$4.35M	–	43
2021 Q1	$4.35M	Buy	+155,900	New	+$4.15M	0.82%	27

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TB Alternative Assets's CC Position: Q2 2021 in Review

TB Alternative Assets sold out of Chemours (CC) in Q2 2021, closing a stake of 155,900 shares — an estimated $4.35M sold.

TB Alternative Assets first reported a position in CC in Q1 2021 and held it in 1 quarter. The position peaked at $4.35M in Q1 2021. 449 funds tracked by Wall St. Rank hold CC as of Q2 2021.

TB Alternative Assets reported no remaining Chemours position as of Q2 2021 after selling out during the quarter.
TB Alternative Assets sold 155,900 Chemours shares in Q2 2021, an estimated $4.35M.
TB Alternative Assets first reported a position in Chemours in Q1 2021 and held it in 1 quarter.
TB Alternative Assets's Chemours position peaked at $4.35M in Q1 2021.
449 funds tracked by Wall St. Rank held Chemours as of Q2 2021.

Based on TB Alternative Assets's 13F filing for Q2 2021, filed 21 Jul 2021.